Found 6 matching trials
The Purpose of the Study is to Continue to Provide Pemigatinib to Patients With Advanced Malignancies.
PHASE2Safety and tolerability of pemigatinib.in monotherapy or combination in pat...
Location
John Wayne Cancer Institute
Neoadjuvant Phase II Study of Pembrolizumab And Carboplatin Plus Docetaxel in Triple Negative Breast Cancer
PHASE2The standard treatment for women with stage I, II, and III triple-negative ...
Location
The University of Kansas Cancer Center (KUCC)
A Study of Pembrolizumab in Combination With Epacadostat in Women With Recurrent/Metastatic Endometrial Carcinoma
PHASE2Expression of IDO and PD-1/L1 has been found to be increased in endometrial...
Location
Fox Chase Cancer Center
Risk-adapted Therapy in HPV-positive Oropharyngeal Cancer Using Circulating Tumor (ct) HPV DNA Profiling (ReACT 2.0)
PHASE2The purpose of this study is to assess risk for HPV driven oropharyngeal ca...
Location
Brigham and Women's Hospital
Pembrolizumab and Carboplatin in Treating Patients With Circulating Tumor Cells Positive Metastatic Breast Cancer
PHASE2The purpose of the study is to evaluate the impact on progression-free surv...
Location
Northwestern University
Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors
PHASE1This study is an open-label Phase 1/Phase 2 evaluation of INCB001158 as a s...
Location
University of South Alabama